Nova Leap Health Corp.
NVLPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $22,274 | $17,463 | $15,769 | $17,432 |
| - Cash | $1,572 | $1,393 | $1,333 | $1,403 |
| + Debt | $3,011 | $3,269 | $3,340 | $2,526 |
| Enterprise Value | $23,713 | $19,339 | $17,776 | $18,555 |
| Revenue | $8,264 | $8,021 | $7,094 | $6,586 |
| % Growth | 3% | 13.1% | 7.7% | – |
| Gross Profit | $3,273 | $3,224 | $2,767 | $2,574 |
| % Margin | 39.6% | 40.2% | 39% | 39.1% |
| EBITDA | $904 | -$263 | $201 | $1,275 |
| % Margin | 10.9% | -3.3% | 2.8% | 19.4% |
| Net Income | $426 | -$484 | -$78 | $886 |
| % Margin | 5.2% | -6% | -1.1% | 13.5% |
| EPS Diluted | 0.005 | -0.006 | -0.001 | 0.01 |
| % Growth | 187.3% | -450% | -109.8% | – |
| Operating Cash Flow | $471 | $612 | $197 | $339 |
| Capital Expenditures | $0 | $0 | $0 | -$25 |
| Free Cash Flow | $471 | $612 | $197 | $314 |